← back to search

Paul Ardayfio

Eli Lilly (United States) · US
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neurotransmitter Receptor Influence on Behavior, and Parkinson's Disease Mechanisms and Treatments.
h-index
18
citations
5,201
works
41
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Donanemab in Early Symptomatic Alzheimer Disease
JAMA 2023cited by 2,415position: middledoi
Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial
Alzheimer s & Dementia 2023cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alette M. Wessels · Eli Lilly (United States)1 papers (2023–2023)Stephen Salloway · Brown University1 papers (2023–2023)Dawn A. Brooks · Eli Lilly (United States)1 papers (2023–2023)Sergey Shcherbinin · Eli Lilly (United States)1 papers (2023–2023)Craig Ritchie · St Andrew's Healthcare1 papers (2023–2023)Liana G. Apostolova · ADS Group1 papers (2023–2023)Daniel Skovronsky · Eli Lilly (United States)1 papers (2023–2023)Oskar Hansson · Medical Research Council1 papers (2023–2023)Emel Serap Monkul Nery · Eli Lilly (United States)1 papers (2023–2023)JonDavid Sparks · Eli Lilly (United States)1 papers (2023–2023)Mark A. Mintun · Resonance Research (United States)1 papers (2023–2023)Hong Wang · Nanjing Forestry University1 papers (2023–2023)Ming Lu · Second Affiliated Hospital of Nanjing Medical University1 papers (2023–2023)Jennifer A. Zimmer · Eli Lilly (United States)1 papers (2023–2023)Paul R. Solomon · Schizophrenia Research Foundation1 papers (2023–2023)John R. Sims · Eli Lilly (United States)1 papers (2023–2023)Cynthia Evans · Eli Lilly (United States)1 papers (2023–2023)